Drugs Made In America Acquisition (DMIIR) Liabilities and Shareholders Equity (2024 - 2025)
Drugs Made In America Acquisition (DMIIR) reported Liabilities and Shareholders Equity of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% on a QoQ basis from $501.0 million in Q3 2025.
Drugs Made In America Acquisition (DMIIR) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $505.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 474.42 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 311.76 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 310.95 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 310.55 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 366.18 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 289.04 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 272.82 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 286.39 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 262.39 Mn |
| 10 | Drugs Made In America Acquisition | - | - | - | 504.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |